Pediatric Surgery International

, Volume 34, Issue 5, pp 573–578 | Cite as

Right trisegmentectomy after portal vein embolization in a high-risk toddler with hepatoblastoma

  • Nhatrang Le
  • Douglas C. Rivard
  • Rebecca M. Rentea
  • Michelle Manalang
  • Walter Andrews
  • Bartholomew Kane
  • Richard J. Hendrickson
Technical Innovation


Portal vein embolization (PVE) is a pre-operative treatment modality in adults undergoing hepatectomy with concerns of post-operative liver failure from insufficient future liver remnant (FLR). PVE induces growth in the FLR. The success of this technique is well described in adults, but not in young children with hepatoblastoma.


Portal vein embolization Hepatoblastoma Hepatectomy Future liver remnant 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Chung EM, Lattin GE, Cube R et al (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation part 2. Malignant tumors. Radiographics 31:483–507. CrossRefPubMedGoogle Scholar
  2. 2.
    Stocker JT (2001) Hepatic tumors in children. Clin Liver Dis 5:259–281 viii–ix.CrossRefPubMedGoogle Scholar
  3. 3.
    Hamilton SR, Aaltonen LA (eds) (2000) World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. IARC Press, LyonGoogle Scholar
  4. 4.
    Spector LG, Puumala SE, Carozza SE et al (2009) Cancer risk among children with very low birth weights. Pediatrics 124:96–104. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    El Asmar A, El Rassi Z (2016) Hepatoblastoma in childhood, long term survival achieved: 2 case reports and literature review. Int J Surg Case Rep 21:55–58. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the US (1992–2004). Cancer 112:416–432. CrossRefPubMedGoogle Scholar
  7. 7.
    Spector LG, Birch J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59:776–779. CrossRefPubMedGoogle Scholar
  8. 8.
    Perilongo G, Shafford E, Plaschkes J, Liver Tumour Study Group of the International Society of Paediatric Oncology (2000) SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 1:94–100CrossRefPubMedGoogle Scholar
  9. 9.
    Allan BJ, Parikh PP, Diaz S et al (2013) Predictors of survival and incidence of hepatoblastoma in the paediatric population. Hpb 15:741–746. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Hiyama E (2014) Pediatric hepatoblastoma: diagnosis and treatment. Transl Pediatr 3:293–299. PubMedPubMedCentralGoogle Scholar
  11. 11.
    De Ioris M, Brugieres L, Zimmermann A et al (2008) Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 44:545–550. CrossRefPubMedGoogle Scholar
  12. 12.
    Czauderna P, Otte JB, Aronson DC et al (2005) Guidelines for surgical treatment of hepatoblastoma in the modern era—recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41:1031–1036. CrossRefPubMedGoogle Scholar
  13. 13.
    Terraz S, Ronot M, Breguet R et al (2015) Portal vein embolization before extended hepatectomy in a toddler with mesenchymal hamartoma. Pediatrics 136:e1055-9. CrossRefPubMedGoogle Scholar
  14. 14.
    May BJ, Talenfeld AD, Madoff DC (2013) Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies. J Vasc Interv Radiol 24:241–254. CrossRefPubMedGoogle Scholar
  15. 15.
    Takayama T, Makuuchi M (2004) Preoperative portal vein embolization: is it useful? J Hepatobiliary Pancreat Surg 11:17–20. CrossRefPubMedGoogle Scholar
  16. 16.
    Avritscher R, Duke E, Madoff DC (2010) Portal vein embolization: Rationale, outcomes, controversies and future directions. Expert Rev Gastroenterol Hepatol 4:489–501. CrossRefPubMedGoogle Scholar
  17. 17.
    Van Lienden KP, Van Den Esschert JW, De Graaf W et al (2013) Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 36:25–34. CrossRefPubMedGoogle Scholar
  18. 18.
    Glantzounis GK, Tokidis E, Basourakos SP et al (2017) The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol 43:32–41. CrossRefPubMedGoogle Scholar
  19. 19.
    Tashiro S (2009) Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different? J Hepatobiliary Pancreat Surg 16:292–299. CrossRefPubMedGoogle Scholar
  20. 20.
    Fausto N, Campbell JS, Riehle KJ (2006) Liver regeneration. Hepatology 43:45–53. CrossRefGoogle Scholar
  21. 21.
    Abdalla EK (2010) Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol 102:960–967. CrossRefPubMedGoogle Scholar
  22. 22.
    Lambotte L, Li B, Lecclercq I et al (2000) The compensatory hyperplasia (liver regeneration) following ligation of a portal branch is initiated before the atrophy of the deprived lobes. J Hepatol 32:940–945. CrossRefPubMedGoogle Scholar
  23. 23.
    Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527PubMedGoogle Scholar
  24. 24.
    Ribero D, Abdalla EK, Madoff DC et al (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94:1386–1394. CrossRefPubMedGoogle Scholar
  25. 25.
    Shindoh J, Tzeng C-WD, Aloia TA et al (2014) Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg 18:45–51. CrossRefPubMedGoogle Scholar
  26. 26.
    Leung U, Simpson AL, Araujo RLC et al (2014) Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg 219:620–630. CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Grigorian A, O’Brien CB (2014) Hepatotoxicity secondary to chemotherapy. J Clin Transl Hepatol 2:95–102. PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Nhatrang Le
    • 1
  • Douglas C. Rivard
    • 1
  • Rebecca M. Rentea
    • 1
  • Michelle Manalang
    • 1
  • Walter Andrews
    • 1
  • Bartholomew Kane
    • 2
  • Richard J. Hendrickson
    • 1
  1. 1.Department of Pediatric SurgeryChildren’s Mercy HospitalKansas CityUSA
  2. 2.University of Kansas Medical CenterKansas CityUSA

Personalised recommendations